Researchers at the University of Oxford have created a calculator to estimate individual risk of serious muscle disorders from statins. The tool, published in The Lancet Digital Health, aims to help patients and doctors make informed treatment decisions. Data shows that over 98% of eligible patients are at low risk, suggesting fears of side effects may be overstated.